NDC 61269-271 – Seroquel Xr
Quetiapine Fumarate 150 mg/1 · Tablet, Extended Release · Oral
Product NDC61269-271
Product details
- Brand name
- Seroquel Xr
- Generic name
- quetiapine
- Labeler
- H2-Pharma, LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA022047
- Marketed since
- February 1, 2009
- Listing expires
- December 31, 2027
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Quetiapine Fumarate 150 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61269-271-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-271-60) | Feb 1, 2009 |
Other Seroquel products
- 0310-0272 Quetiapine Fumarate 200 mg/1 · Tablet, Film Coated · AstraZeneca Pharmaceuticals LP
- 0310-0274 Quetiapine Fumarate 300 mg/1 · Tablet, Film Coated · AstraZeneca Pharmaceuticals LP
- 0310-0275 Quetiapine Fumarate 25 mg/1 · Tablet, Film Coated · AstraZeneca Pharmaceuticals LP
- 0310-0278 Quetiapine Fumarate 50 mg/1 · Tablet, Film Coated · AstraZeneca Pharmaceuticals LP
- 0310-0279 Quetiapine Fumarate 400 mg/1 · Tablet, Film Coated · AstraZeneca Pharmaceuticals LP
- 0310-0281 Quetiapine Fumarate 150 mg/1 · Tablet, Extended Release · AstraZeneca Pharmaceuticals LP
- 0310-0282 Quetiapine Fumarate 200 mg/1 · Tablet, Extended Release · AstraZeneca Pharmaceuticals LP
- 0310-0283 Quetiapine Fumarate 300 mg/1 · Tablet, Extended Release · AstraZeneca Pharmaceuticals LP
- 0310-0284 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · AstraZeneca Pharmaceuticals LP
- 0310-0271 Quetiapine Fumarate 100 mg/1 · Tablet, Film Coated · AstraZeneca Pharmaceuticals LP
- 61269-274 Quetiapine Fumarate 400 mg/1 · Tablet, Extended Release · H2-Pharma, LLC
- 61269-273 Quetiapine Fumarate 300 mg/1 · Tablet, Extended Release · H2-Pharma, LLC